<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group><journal-title>PLoS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, CA USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">29489818</article-id><article-id pub-id-type="pmc">5830038</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0190556</article-id><article-id pub-id-type="publisher-id">PONE-D-17-23751</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Metabolism</subject><subj-group><subject>Carbohydrate Metabolism</subject><subj-group><subject>Glucose Metabolism</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Physical Sciences</subject><subj-group><subject>Chemistry</subject><subj-group><subject>Chemical Elements</subject><subj-group><subject>Oxygen</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and Analysis Methods</subject><subj-group><subject>Bioassays and Physiological Analysis</subject><subj-group><subject>Cardiovascular Analysis</subject><subj-group><subject>Cerebral Blood Flow Assay</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and Analysis Methods</subject><subj-group><subject>Bioassays and Physiological Analysis</subject><subj-group><subject>Metabolic Analysis</subject><subj-group><subject>Cerebral Metabolic Rate Assay</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Metabolism</subject><subj-group><subject>Oxygen Metabolism</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Physical Sciences</subject><subj-group><subject>Chemistry</subject><subj-group><subject>Chemical Compounds</subject><subj-group><subject>Acids</subject><subj-group><subject>Ketones</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Body Fluids</subject><subj-group><subject>Blood</subject><subj-group><subject>Blood Flow</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Body Fluids</subject><subj-group><subject>Blood</subject><subj-group><subject>Blood Flow</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Body Fluids</subject><subj-group><subject>Blood</subject><subj-group><subject>Blood Flow</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Body Fluids</subject><subj-group><subject>Blood</subject><subj-group><subject>Blood Flow</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and Analysis Methods</subject><subj-group><subject>Imaging Techniques</subject><subj-group><subject>Neuroimaging</subject><subj-group><subject>Positron Emission Tomography</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Neuroscience</subject><subj-group><subject>Neuroimaging</subject><subj-group><subject>Positron Emission Tomography</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Diagnostic Medicine</subject><subj-group><subject>Diagnostic Radiology</subject><subj-group><subject>Tomography</subject><subj-group><subject>Positron Emission Tomography</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and Analysis Methods</subject><subj-group><subject>Imaging Techniques</subject><subj-group><subject>Diagnostic Radiology</subject><subj-group><subject>Tomography</subject><subj-group><subject>Positron Emission Tomography</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Radiology and Imaging</subject><subj-group><subject>Diagnostic Radiology</subject><subj-group><subject>Tomography</subject><subj-group><subject>Positron Emission Tomography</subject></subj-group></subj-group></subj-group></subj-group></subj-group></article-categories><title-group><article-title>Regional cerebral effects of ketone body infusion with 3-hydroxybutyrate in humans: Reduced glucose uptake, unchanged oxygen consumption and increased blood flow by positron emission tomography. A randomized, controlled trial</article-title><alt-title alt-title-type="running-head">3-hydroxybuturate reduces cerebral glucose uptake and increases cerebral blood flow in humans</alt-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-9574-0612</contrib-id><name><surname>Svart</surname><given-names>Mads</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Data curation</role><role content-type="http://credit.casrai.org/">Formal analysis</role><role content-type="http://credit.casrai.org/">Funding acquisition</role><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Project administration</role><role content-type="http://credit.casrai.org/">Writing &#x02013; original draft</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="aff" rid="aff002"><sup>2</sup></xref><xref ref-type="corresp" rid="cor001">*</xref></contrib><contrib contrib-type="author"><name><surname>Gormsen</surname><given-names>Lars C.</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Formal analysis</role><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Project administration</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff003"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Hansen</surname><given-names>Jakob</given-names></name><role content-type="http://credit.casrai.org/">Data curation</role><role content-type="http://credit.casrai.org/">Formal analysis</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff004"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Zeidler</surname><given-names>Dora</given-names></name><role content-type="http://credit.casrai.org/">Data curation</role><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff005"><sup>5</sup></xref></contrib><contrib contrib-type="author"><name><surname>Gejl</surname><given-names>Michael</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Formal analysis</role><role content-type="http://credit.casrai.org/">Project administration</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff006"><sup>6</sup></xref><xref ref-type="aff" rid="aff007"><sup>7</sup></xref></contrib><contrib contrib-type="author"><name><surname>Vang</surname><given-names>Kim</given-names></name><role content-type="http://credit.casrai.org/">Formal analysis</role><role content-type="http://credit.casrai.org/">Visualization</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff003"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Aanerud</surname><given-names>Joel</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Formal analysis</role><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Project administration</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff003"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Moeller</surname><given-names>Niels</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Formal analysis</role><role content-type="http://credit.casrai.org/">Funding acquisition</role><role content-type="http://credit.casrai.org/">Project administration</role><role content-type="http://credit.casrai.org/">Supervision</role><role content-type="http://credit.casrai.org/">Writing &#x02013; original draft</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="aff" rid="aff002"><sup>2</sup></xref></contrib></contrib-group><aff id="aff001"><label>1</label>
<addr-line>Department of Internal Medicine and Endocrinology, Aarhus University Hospital, Aarhus, Denmark</addr-line></aff><aff id="aff002"><label>2</label>
<addr-line>Department of Clinical Medicine, Aarhus University Hospital, Aarhus, Denmark</addr-line></aff><aff id="aff003"><label>3</label>
<addr-line>Department of Nuclear Medicine and PET Center, Aarhus University Hospital, Aarhus, Denmark</addr-line></aff><aff id="aff004"><label>4</label>
<addr-line>Section for Forensic Chemistry, Department of Forensic Medicine, Aarhus University Hospital, Aarhus, Denmark</addr-line></aff><aff id="aff005"><label>5</label>
<addr-line>Centre of Functionally Integrative Neuroscience (CFIN) and MINDLab, Department of Clinical Medicine, Aarhus University Hospital, Aarhus, Denmark</addr-line></aff><aff id="aff006"><label>6</label>
<addr-line>Institute of Biomedicine, Aarhus University, Aarhus, Denmark</addr-line></aff><aff id="aff007"><label>7</label>
<addr-line>Department of Clinical Biochemistry, Aarhus University Hospital, Aarhus, Denmark</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Scholey</surname><given-names>Andrew</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1"><addr-line>Swinburne University, AUSTRALIA</addr-line></aff><author-notes><fn fn-type="COI-statement" id="coi001"><p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p></fn><corresp id="cor001">* E-mail: <email>mvsv@clin.au.dk</email></corresp></author-notes><pub-date pub-type="epub"><day>28</day><month>2</month><year>2018</year></pub-date><pub-date pub-type="collection"><year>2018</year></pub-date><volume>13</volume><issue>2</issue><elocation-id>e0190556</elocation-id><history><date date-type="received"><day>22</day><month>6</month><year>2017</year></date><date date-type="accepted"><day>16</day><month>12</month><year>2017</year></date></history><permissions><copyright-statement>&#x000a9; 2018 Svart et al</copyright-statement><copyright-year>2018</copyright-year><copyright-holder>Svart et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="pone.0190556.pdf"/><abstract><p>Ketone bodies are neuroprotective in neurological disorders such as epilepsy. We randomly studied nine healthy human subjects twice&#x02014;with and without continuous infusion of 3-hydroxybutyrate&#x02013;to define potential underlying mechanisms, assessed regionally (parietal, occipital, temporal, cortical grey, and frontal) by PET scan. During 3-hydroxybutyrate infusions concentrations increased to 5.5&#x000b1;0.4 mmol/l and cerebral glucose utilisation decreased 14%, oxygen consumption remained unchanged, and cerebral blood flow increased 30%. We conclude that acute 3-hydroxybutyrate infusion reduces cerebral glucose uptake and increases cerebral blood flow in all measured brain regions, without detectable effects on cerebral oxygen uptake though oxygen extraction decreased. Increased oxygen supply concomitant with unchanged oxygen utilisation may contribute to the neuroprotective effects of ketone bodies.</p></abstract><funding-group><award-group id="award001"><funding-source><institution-wrap><institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100007398</institution-id><institution>Strategiske Forskningsr&#x000e5;d</institution></institution-wrap></funding-source><award-id>0603-00479B</award-id><principal-award-recipient><name><surname>Moeller</surname><given-names>Niels</given-names></name></principal-award-recipient></award-group><award-group id="award002"><funding-source><institution-wrap><institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100003035</institution-id><institution>Aase og Ejnar Danielsens Fond</institution></institution-wrap></funding-source><award-id>10-001731</award-id><principal-award-recipient><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-9574-0612</contrib-id><name><surname>Svart</surname><given-names>Mads</given-names></name></principal-award-recipient></award-group><award-group id="award003"><funding-source><institution>Ferdinand og Ellen Hindsgauls Fond</institution></funding-source><award-id>102559</award-id><principal-award-recipient><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-9574-0612</contrib-id><name><surname>Svart</surname><given-names>Mads</given-names></name></principal-award-recipient></award-group><award-group id="award004"><funding-source><institution-wrap><institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100007420</institution-id><institution>L&#x000e6;geforeningen</institution></institution-wrap></funding-source><award-id>2016-1840/1</award-id><principal-award-recipient><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-9574-0612</contrib-id><name><surname>Svart</surname><given-names>Mads</given-names></name></principal-award-recipient></award-group><funding-statement>This work was funded by the Danish Council for Strategic Research (grant no.0603-00479B), Aase Danielsen Fund(10-001731), Ferd. Og Ellen Hindsgauls Fund (J.nr.102559), and the Danish Medical Association(Jnr.2016-1840/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts><fig-count count="3"/><table-count count="1"/><page-count count="12"/></counts><custom-meta-group><custom-meta id="data-availability"><meta-name>Data Availability</meta-name><meta-value>All relevant data are within the paper and its Supporting Information files.</meta-value></custom-meta></custom-meta-group></article-meta><notes><title>Data Availability</title><p>All relevant data are within the paper and its Supporting Information files.</p></notes></front><body><sec sec-type="intro" id="sec001"><title>Introduction</title><p>In evolutionary terms the ability to generate ketone bodies (3-hydroxybutyrate(3-OHB) and acetoacetate) has been fundamental for mankind surviving times of dwindling food supplies and ketosis induced by fasting, exercise, and&#x02014;most recently&#x02013;antidiabetic treatment with SGLT2-inhibitors may increase longevity in humans[<xref rid="pone.0190556.ref001" ref-type="bibr">1</xref>, <xref rid="pone.0190556.ref002" ref-type="bibr">2</xref>]; it has also been reported that specific supplementation with 3-OHB increases lifespan in <italic>C</italic>. <italic>Elegans</italic> roundworms by 20%[<xref rid="pone.0190556.ref003" ref-type="bibr">3</xref>].</p><p>The brain relies on a constant rate of energy supply[<xref rid="pone.0190556.ref004" ref-type="bibr">4</xref>] and during metabolic stress eg. fasting, exercise, or severe disease, ketone bodies displace glucose as oxidative fuel[<xref rid="pone.0190556.ref005" ref-type="bibr">5</xref>, <xref rid="pone.0190556.ref006" ref-type="bibr">6</xref>]. In hyperketonemic states 3-OHB is present in several fold higher concentration than acetoacetate[<xref rid="pone.0190556.ref007" ref-type="bibr">7</xref>] and there is evidence that 3-OHB promotes a more efficient ATP yield per oxygen molecule compared to lipid and carbohydrate fuels[<xref rid="pone.0190556.ref008" ref-type="bibr">8</xref>, <xref rid="pone.0190556.ref009" ref-type="bibr">9</xref>]. Furthermore, 3-OHB has been reported to lower reactive oxygen species (ROS) dependent oxidative stress in the central nervous system (CNS)[<xref rid="pone.0190556.ref010" ref-type="bibr">10</xref>, <xref rid="pone.0190556.ref011" ref-type="bibr">11</xref>], to inhibit histone deacetylase(HDAC) induced oxidative stress[<xref rid="pone.0190556.ref012" ref-type="bibr">12</xref>], and to promote the expression of brain derived neurotrophic factor [<xref rid="pone.0190556.ref013" ref-type="bibr">13</xref>]. A ketogenic diet has proven beneficial in the treatment of epilepsy and may also have favorable effects in the treatment of neurodegenerative diseases e.g. Alzheimer's and Parkinson's disease which are most prevalent in elderly people [<xref rid="pone.0190556.ref014" ref-type="bibr">14</xref>&#x02013;<xref rid="pone.0190556.ref017" ref-type="bibr">17</xref>].</p><p>Our knowledge on the effects of ketone bodies on cerebral blood flow (CBF) and metabolism is limited, in paticular as regards acute hyperketonemia. Chronic hyperketonaemia in humans has been shown to induce a potent 50% reduction in global cerebral metabolic rate of glucose (CMR<sub>glu</sub>) after 4&#x02013;6 weeks of fasting resulting in 3-OHB concentrations between 4&#x02013;8 mmol/l [<xref rid="pone.0190556.ref004" ref-type="bibr">4</xref>, <xref rid="pone.0190556.ref018" ref-type="bibr">18</xref>] and animal studies have suggested a 9% decline in glucose utlisation per 1 mmol increase in ketone bodies [<xref rid="pone.0190556.ref019" ref-type="bibr">19</xref>]. Acute studies in rats using the Kety-Schmidt technique have reported, that 3-OHB infusion increases global cerebral blood flow by 65% without altering oxygen or glucose metabolic rates[<xref rid="pone.0190556.ref020" ref-type="bibr">20</xref>]. One study in humans using the same technique with <sup>133</sup>Xe dilution and internal jugular vein catheters found 40% increased CBF, 30% reduced CMR<sub>glu</sub> and unaltered oxygen utilisation[<xref rid="pone.0190556.ref021" ref-type="bibr">21</xref>] after 3-OHB infusion in the fed state. Yet another study in humans also using internal jugular vein catheters showed unaltered CMR<sub>glu</sub> and did not report measures of CBF or oxygen utilisation [<xref rid="pone.0190556.ref022" ref-type="bibr">22</xref>]; both studies used relatively low infusion rates with 3-OHB concentrations of ~ 2mmol/l and enrolled relatively young subjects with a mean age of 25 years. Human cerebral glucose utilisation decreases throughout life as well in human as in rats [<xref rid="pone.0190556.ref023" ref-type="bibr">23</xref>, <xref rid="pone.0190556.ref024" ref-type="bibr">24</xref>]. Additionally, it is a prominent feature of mandis a prominent feature of upling our study design to studying elderly subjects. sed. not likely that it would have decresed Alzheimer&#x02019;s disease patients and most neurogegenerative diseases affects elderly people[<xref rid="pone.0190556.ref025" ref-type="bibr">25</xref>]. Therefore, our study was designed to test whether an acute 4-h, high dose 3-OHB infusion affects CBF and oxygen and glucose utilisation in elderly humans, using PET and MRI with labeled [<sup>15</sup>O]H<sub>2</sub>O, [<sup>15</sup>O]O<sub>2</sub> and [<sup>18</sup>F]FDG to assess regional CNS events.</p></sec><sec sec-type="materials|methods" id="sec002"><title>Material and methods</title><sec id="sec003"><title>Study participants</title><p>Nine healthy subjects were recruited after a screening procedure to ensure eligibility using the following inclusion and exclusion criteria. Inclusion criteria: Age 50&#x02013;70 years, male or female, and body mass index (BMI) 20&#x02013;30 kg/m<sup>2.</sup> Exclusion criteria: Severe comorbidity, blood donation &#x0003c; 6 months, smooking, alcohol or drug abuse, clustrofobia, and participation in trials including radiation within the last 12 monts. All participants signed consent forms before enrolling. Screening and trial was carried out at the Aarhus University Hospital. The study was not blinded. Randomization sequence was generated at <ext-link ext-link-type="uri" xlink:href="http://www.randomizer.org">www.randomizer.org</ext-link> before the study was started.</p><p>The Danish Mid-Regional Ethics Committee approved the study (1-10-72-106-14), which was carried out in accordance with the declaration of Helsinki and registered at <ext-link ext-link-type="uri" xlink:href="http://www.clinicaltrials.gov/">www.clinicaltrials.gov</ext-link> (ID number: NCT02357550).</p></sec><sec id="sec004"><title>Study protocol</title><p>We used a randomized, controlled crossover design with two arms separated by at least 2 weeks: i) saline infusion (0.9%) (CTR) and ii) ketone body infusion with 3-OHB (75g/liter) (KET).</p><p>Subjects were fasting overnight before each trial day. In the morning at 8 AM two catheters were placed in each antecubital vein; one for infusion and one for blood sampling, and an arterial cathether was placed in the radial artery. Infusions were started at 0 minutes and continued for 240 minutes. PET scans were performed at 120 min (1000 mBq <sup>15</sup>O-O<sub>2</sub>), 150 min (500 mBq <sup>15</sup>O-H<sub>2</sub>O), and 180 min (150 mBq <sup>18</sup>F-FDG). During all scans the subjects were in the supine position with eyes closed. Blood samples were drawn hourly or &#x000bd;hourly as indicated in <xref ref-type="fig" rid="pone.0190556.g001">Fig 1</xref>.</p><fig id="pone.0190556.g001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0190556.g001</object-id><label>Fig 1</label><caption><title>Flowchart.</title><p>The flowchart illustrates the study design and shows the duration of 3-hydroxybuturate (3-OHB)/saline, and the timing of the three different scans and blood sampling.</p></caption><graphic xlink:href="pone.0190556.g001"/></fig></sec><sec id="sec005"><title>3-hydroxybuturate and saline</title><p>We infused DL-3-Hydroxybutyric acid, sodium salt (Gold Biotechnology, St Louis, MO) for four hours at a concentration of 75g 3-OHB/l and an infusion rate of 0.22 g/kg/hour. In the CTR isotonic saline was infused with a corresponding infusion rate.</p></sec><sec id="sec006"><title>Plasma metabolites</title><p>Blood samples were stored at -20&#x000b0;C until analyzed. Serum FFA concentrations were quantified using enzymatic colorimetric method assay NEFA-HR (Wako Chemicals GmbH, Germany), serum lactate and glucose by immobilized enzyme biosensor technology (YSI 2300 model Stat Plus, Bie &#x00026; Berntsen, Denmark). Serum concentrations of 3-OHB were measured using liquid chromatography tandem mass spectrometry[<xref rid="pone.0190556.ref026" ref-type="bibr">26</xref>].</p><p>Serum cortisol concentrations were determined by ELISA (DRG Cortisol Enzyme Immunoassay Kit, Germany), serum glucagon concentrations using a radioimmunoassay (EMD Millipore's Glucagon Radioimmunoassay Kit, Germany), and serum growth hormone concentrations using chemi-luminescence technology (IDS-iSYS hGH, Immunodiagnostic Systems Ltd, England).</p></sec><sec id="sec007"><title>MR</title><p>A high-resolution 3D T1 weighted sequence was performed using a 32 channel head coil on a standard clinical 3T MAGNETOM Trio system (Siemens Healthcare, Erlangen, Germany) using a 3D T1 MPRAGE sequence with 176 slices, 1 x 1 x 1 voxel size, FOV 256 mm, TE = 3.7 ms, TR = 2420 ms, TI = 960 ms, flip angel = 9, iPAT = 2, 1 acquisition and with an acquisition time of 10:55. The MRI was done at the time of screening.</p></sec><sec id="sec008"><title>PET scan protocols</title><p>All PET-images were obtained on a High Resolution Research Tomograph (Siemens Medical Solutions, Knoxville, TN, USA) in list mode. [<sup>15</sup>O]H<sub>2</sub>O-scans lasted five minutes and were reconstructed into 36 x 5 s, 6 x 10 s, and 3 x 20 s time frames. [<sup>15</sup>O]O<sub>2</sub>-scans lasted three minutes and were reconstructed into 12 x 5 s, 6 x 10 s, and 3 x 20 s time frames. [<sup>18</sup>F]FDG-scans lasted 60 minutes and were reconstructed into 6 x 10 s, 2 x 30 s, 4 x 60 s, 2 x 120 s, 2 x 300 s, and 4 x 600 s time frames. Arterial blood sampling was started simultaneously with tracer administration, and lasted for the duration of each scan. For [<sup>15</sup>O]H<sub>2</sub>O-scans, [<sup>15</sup>O]O<sub>2</sub>-scans, and the first 10 minutes of [<sup>18</sup>F]FDG-scans an Allogg automated blood sampler was used (Allogg AB, Mariefred, Sweden) to measure arterial radioactivity. During the last 50 minutes of [<sup>18</sup>F]FDG-scans, manual blood samples were taken at 10, 12, 17, 25, 35, 45, and 55 minutes, and activity counted on a Packard Cobra II system (Packard Instrument Company, Meriden, CT, USA). PET images were acquired in 1.22 mm steps isometric, with a field of view of 312 x 312 x 252 mm (x,y,z respectively).</p><p>PET images were coregistered to each individual's T1-weighted MRI. All MRI's were coregistered, by a combination of linear and non-linear coregistration, to a template consisting of 85 brains from young healthy people in ICBM152 space [<xref rid="pone.0190556.ref027" ref-type="bibr">27</xref>].</p><p>Co-registration was done with in-house software using an in-house MRI atlas in MNI-space, generic masks correspond to MNI coordinates. Transformations for PET-to-MRI and MRI-to-template were concatenated, and the resulting transformations were applied to dynamic PET-series to render them in common space. The automated coregistration algorithm extracted binary masks of cortical grey matter, which were multiplied with generic masks for each volume of interest.</p><p>Dynamic [<sup>15</sup>O]H<sub>2</sub>O- and [<sup>15</sup>O]O<sub>2</sub>-scans in common space were blurred to full-width half-maximum 7 mm. Parametric images of the unidirectional clearances (<italic>K</italic><sub><italic>1</italic></sub>) of the two tracers were then calculated with the linearized two-compartement model [<xref rid="pone.0190556.ref028" ref-type="bibr">28</xref>], modified by Ohta <italic>et al [<xref rid="pone.0190556.ref029" ref-type="bibr">29</xref>, <xref rid="pone.0190556.ref030" ref-type="bibr">30</xref>]</italic>. Cerebral metabolic rate of oxygen (CMR<sub>o2</sub>) was calculated by multiplying <italic>K</italic><sub><italic>1</italic></sub> voxel-maps of [<sup>15</sup>O]O<sub>2</sub>-scans with arterial oxygen concentration. The Lawson and Hanson non-negative least squares method was used to solve general least squares functions. We calculated parametric maps of CMR<sub>glu</sub> using the Patlak method[<xref rid="pone.0190556.ref031" ref-type="bibr">31</xref>] with a lumped constant of 0.8[<xref rid="pone.0190556.ref032" ref-type="bibr">32</xref>]. Regions of interest were cortical grey matter, parietal, temporal, frontal, and occipital regions.</p></sec><sec id="sec009"><title>Statistical analysis</title><p>Normal distribution of data was ensured by inspection of QQ-plots. The results are presented as means &#x000b1; standard error of the mean (SEM), unless otherwise specified. The power calculation for the primary endpoint (CMR<sub>glu</sub>) as comparison of two paired means with significance level = 0.05, power = 0.8, difference of means = 3 umol/100 g brain tissue/min, and standard deviation of the mean = 2 umol/100 g brain tissue/min. This gave a sample size of N = 6. We included nine to ensure secondary outcomes as well. Secondary outcomes were CBF and CMR<sub>o2</sub>. Unequally distributed data were logarithmically transformed. Statistical association of the two trial days was tested using a paired two-tailed student&#x02019;s t-test with eight degrees of freedom (t-test) and two-way repeated measure ANOVA analysis (ANOVA) when relevant. In case of significant main effect, pairwise comparison was made post hoc using a student&#x02019;s paired, two-tailed t-test. A p-value &#x0003c;0.05 was considered significant. Graphs and statistical analysis were done using Stata 13 (College Station, Texas, USA) and Sigmaplot 11 (San Jose, California, USA).</p></sec></sec><sec sec-type="results" id="sec010"><title>Results</title><p>All nine subjects (four women), age 62 (range 56&#x02013;69) and BMI 24&#x000b1;2 kg/m<sup>2</sup> completed the two trial days and are included in the analyses. There were no adverse events. The intervention of infusing 3-OHB increased 3-OHB concentrations to 5.5&#x000b1;0.4 mmol/l during KET vs 0.2&#x000b1;0.02 during CTR, <italic>p</italic>&#x0003c;0.001 (main effect, ANOVA) (<xref ref-type="fig" rid="pone.0190556.g002">Fig 2A</xref>). Associated with the the increase in 3-OHB, the FFAs decreased significantly throughout the day during KET (<xref ref-type="fig" rid="pone.0190556.g002">Fig 2B</xref>).</p><fig id="pone.0190556.g002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0190556.g002</object-id><label>Fig 2</label><caption><title>Metabolic parameters in the blood.</title><p>Results are shown for n = 9 on Control day (CTR) and day with 3-hydroxybuturate (3-OHB) infusion (KET). Two-way repeated measures ANOVA analysis was used to test for differences between the two days. * = <italic>p</italic> &#x0003c;0.05. Open circles illustrate the mean value (&#x000b1;SE) on the KET day and closed circles illustrate the mean value (&#x000b1;SE) on the CTR day. Plasma 3-OHB (A) was measured every 30 minutes. Plasma free fatty acids (B) and insulin (C) was measured every hour. Plasma glucose (D) was measured every 30 minutes and lactate (E) at 0, 120, 180, and 240 minutes.</p></caption><graphic xlink:href="pone.0190556.g002"/></fig><p>Glucagon levels 57.8&#x000b1;5.5 pg/ml in KET vs 58.8&#x000b1;4.1 pg/ml in CTR and cortisol levels 119.7&#x000b1;21.7 ng/ml in KET vs 151.3&#x000b1;26.8 ng/ml in CTR were comparable, whereas growth hormone was significantly higher during KET (5.65&#x000b1;1.67 pmol/l) compared with CTR (1.82&#x000b1;0.80 pmol/l), p = 0.03 (t-test).</p><sec id="sec011"><title>Cerebral glucose metabolism decreases during hyperketonemia</title><p>During acute hyperketonemia CMR<sub>glu</sub> was reduced 14% in cortical grey matter; KET (19.6&#x000b1;0.8 mmol/100g/min) compared with CTR (22.8&#x000b1;1.3 mmol/100g/min), p = 0.02 (t-test) (<xref ref-type="fig" rid="pone.0190556.g003">Fig 3A</xref>). The same was found in frontal, temporal, parietal, and occipital regions, with the largest reduction in the frontal region <xref ref-type="table" rid="pone.0190556.t001">Table 1</xref>. Plasma insulin concentrations declined comparably throughout both study days (<xref ref-type="fig" rid="pone.0190556.g002">Fig 2C</xref>), and plasma glucose concentrations remained slightly lower during KET compared with CTR, p&#x0003c;0.001 (main effect, ANOVA) (<xref ref-type="fig" rid="pone.0190556.g002">Fig 2D</xref>) at the time of FDG-scan for CMR<sub>glu</sub>. Lactate concentration was higher (p = 0.02 (main effect, ANOVA)) during KET compared with CTR (<xref ref-type="fig" rid="pone.0190556.g002">Fig 2E</xref>).</p><fig id="pone.0190556.g003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0190556.g003</object-id><label>Fig 3</label><caption><title>Individual PET-scan values.</title><p>Results are shown for n = 9 on control day (CTR) and day with 3-hydroxybuturate (3-OHB) infusion (KET). Two-tailed T-test was used to test for difference between the two days. * = <italic>p</italic> &#x0003c;0.05. Data is presented as dot plots and each dot represents an individual value. The horizontal mean line indicates the mean value for each group. Cerebral metabolic rate for glucose (CMR<sub>glucose</sub>) (A) was measured at 180&#x02013;240 minutes. Cerebral blood flow (B) was measured at 120&#x02013;130 minutes. Cerebral metabolic rate for oxygen (CMR<sub>o2</sub>) (C) was measured at 90&#x02013;100 minutes.</p></caption><graphic xlink:href="pone.0190556.g003"/></fig><table-wrap id="pone.0190556.t001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0190556.t001</object-id><label>Table 1</label><caption><title>Regional changes in cerebral metabolism during ketone body infusion.</title></caption><alternatives><graphic id="pone.0190556.t001g" xlink:href="pone.0190556.t001"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1"><underline>CMR</underline><sub><underline>glu</underline></sub>: umol/100g/min</th><th align="center" rowspan="1" colspan="1">CTR</th><th align="center" rowspan="1" colspan="1">KET</th><th align="center" rowspan="1" colspan="1">Difference of means<break/>(%-change from CTR)</th><th align="center" rowspan="1" colspan="1">P value</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Frontal</td><td align="left" rowspan="1" colspan="1">24.3&#x000b1;1.4</td><td align="left" rowspan="1" colspan="1">20.7&#x000b1;0.9</td><td align="center" rowspan="1" colspan="1">3.5 (14.4)</td><td align="left" rowspan="1" colspan="1"><bold>0.02</bold></td></tr><tr><td align="left" rowspan="1" colspan="1">Parietal</td><td align="left" rowspan="1" colspan="1">22.9&#x000b1;1.3</td><td align="left" rowspan="1" colspan="1">19.8&#x000b1;0.8</td><td align="center" rowspan="1" colspan="1">3.1 (13.5)</td><td align="left" rowspan="1" colspan="1"><bold>0.02</bold></td></tr><tr><td align="left" rowspan="1" colspan="1">Temporal</td><td align="left" rowspan="1" colspan="1">20.6&#x000b1;1.2</td><td align="left" rowspan="1" colspan="1">17.7&#x000b1;0.7</td><td align="center" rowspan="1" colspan="1">2.9 (14.1)</td><td align="left" rowspan="1" colspan="1"><bold>0.02</bold></td></tr><tr><td align="left" rowspan="1" colspan="1">Occipital</td><td align="left" rowspan="1" colspan="1">21.8&#x000b1;1.1</td><td align="left" rowspan="1" colspan="1">19.1&#x000b1;0.9</td><td align="center" rowspan="1" colspan="1">2.8 (12.8)</td><td align="left" rowspan="1" colspan="1"><bold>0.03</bold></td></tr><tr><td align="left" rowspan="1" colspan="1">Cortical grey</td><td align="left" rowspan="1" colspan="1">22.8&#x000b1;1,3</td><td align="left" rowspan="1" colspan="1">19.6&#x000b1;0.8</td><td align="center" rowspan="1" colspan="1">3.2 (14.0)</td><td align="left" rowspan="1" colspan="1"><bold>0.02</bold></td></tr><tr><td align="left" rowspan="1" colspan="1"><underline><bold>CBF:</bold></underline> umol/100g/min</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Frontal</td><td align="left" rowspan="1" colspan="1">41.6&#x000b1;2.3</td><td align="left" rowspan="1" colspan="1">54.2&#x000b1;2.2</td><td align="center" rowspan="1" colspan="1">12.6 (30.2)</td><td align="left" rowspan="1" colspan="1"><bold>0.0007</bold></td></tr><tr><td align="left" rowspan="1" colspan="1">Parietal</td><td align="left" rowspan="1" colspan="1">40.9&#x000b1;2.1</td><td align="left" rowspan="1" colspan="1">52.5&#x000b1;2.0</td><td align="center" rowspan="1" colspan="1">11.5 (28.1)</td><td align="left" rowspan="1" colspan="1"><bold>0.0007</bold></td></tr><tr><td align="left" rowspan="1" colspan="1">Temporal</td><td align="left" rowspan="1" colspan="1">36.5&#x000b1;1.9</td><td align="left" rowspan="1" colspan="1">47.4&#x000b1;1.9</td><td align="center" rowspan="1" colspan="1">11.0 (30.1)</td><td align="left" rowspan="1" colspan="1"><bold>0.0004</bold></td></tr><tr><td align="left" rowspan="1" colspan="1">Occipital</td><td align="left" rowspan="1" colspan="1">42.2&#x000b1;2.0</td><td align="left" rowspan="1" colspan="1">52.3&#x000b1;1.6</td><td align="center" rowspan="1" colspan="1">10.1 (23.9)</td><td align="left" rowspan="1" colspan="1"><bold>0.0007</bold></td></tr><tr><td align="left" rowspan="1" colspan="1">Cortical grey</td><td align="left" rowspan="1" colspan="1">40.4&#x000b1;2.1</td><td align="left" rowspan="1" colspan="1">52.0&#x000b1;2.0</td><td align="center" rowspan="1" colspan="1">11.6 (28.9)</td><td align="left" rowspan="1" colspan="1"><bold>0.0006</bold></td></tr><tr><td align="left" rowspan="1" colspan="1"><underline><bold>CMR</bold></underline><sub><underline><bold>o2</bold></underline></sub><underline>:</underline> umol/100ml/min</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Frontal</td><td align="left" rowspan="1" colspan="1">127.6&#x000b1;5.0</td><td align="left" rowspan="1" colspan="1">125.6&#x000b1;3.1</td><td align="center" rowspan="1" colspan="1">2.0 (1.6)</td><td align="left" rowspan="1" colspan="1">0.74</td></tr><tr><td align="left" rowspan="1" colspan="1">Parietal</td><td align="left" rowspan="1" colspan="1">131.2&#x000b1;4.6</td><td align="left" rowspan="1" colspan="1">127.5&#x000b1;4.2</td><td align="center" rowspan="1" colspan="1">3.7 (2.8)</td><td align="left" rowspan="1" colspan="1">0.55</td></tr><tr><td align="left" rowspan="1" colspan="1">Temporal</td><td align="left" rowspan="1" colspan="1">117.1&#x000b1;3.8</td><td align="left" rowspan="1" colspan="1">117.1&#x000b1;3.4</td><td align="center" rowspan="1" colspan="1">0.0 (0)</td><td align="left" rowspan="1" colspan="1">0.99</td></tr><tr><td align="left" rowspan="1" colspan="1">Occipital</td><td align="left" rowspan="1" colspan="1">142.2&#x000b1;4.5</td><td align="left" rowspan="1" colspan="1">139.1&#x000b1;5.3</td><td align="center" rowspan="1" colspan="1">3.1 (2.2)</td><td align="left" rowspan="1" colspan="1">0.65</td></tr><tr><td align="left" rowspan="1" colspan="1">Cortical grey</td><td align="left" rowspan="1" colspan="1">128.1&#x000b1;4.4</td><td align="left" rowspan="1" colspan="1">126.0&#x000b1;3.6</td><td align="center" rowspan="1" colspan="1">2.1 (1.6)</td><td align="left" rowspan="1" colspan="1">0.71</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t001fn001"><p>In Table 1 we report absolute regional changes in PET-determined brain metabolism from the two experimental conditions KET-ketone body infusion and CTR-saline infusion; cerebral metabolic rate for glucose (CMR<sub>glu</sub>), cerebral blood flow (CBF), and cerebral metabolic rate for oxygen (CMR<sub>o2</sub>). A student&#x02019;s paired two-tailed t-test was used to test for difference with eight degrees of freedom.</p></fn></table-wrap-foot></table-wrap></sec><sec id="sec012"><title>Blood flow in the brain increases during hyperketonaemia</title><p>CBF increased 30% during acute hyperketonemia in cortical grey matter during KET (52.0&#x000b1;2.0 ml/100 g/min) compared with CTR (40.9&#x000b1;2.1 ml/100 g/min), p&#x0003c;0.001(t-test) (<xref ref-type="fig" rid="pone.0190556.g003">Fig 3B</xref>), the same pattern being observed in the frontal, temporal, parietal and occipital regions, <xref ref-type="table" rid="pone.0190556.t001">Table 1</xref>. The frontal region accounting for the biggest increase. Heart rate increased during KET (14&#x000b1;2 beats per minute) compared with CTR (2&#x000b1;1 beats per minute), p&#x0003c;0.001 (t-test). We found no difference in mean arterial pressure 100&#x000b1;3 mmHg(CTR) vs 97 mmHg(KET), p = 0.24 (t-test). Arterial carbondioxide concentration and pH was unchanged in the two conditions and arterial oxygen partial pressure was slightly and significantly higher during CTR (10.5&#x000b1;1.1 kPa) compared with KET (9.5&#x000b1;1.2 kPa), p = 0.01 (t-test).</p></sec><sec id="sec013"><title>Cerebral oxygen consumption is unaltered during hyperketonaemia</title><p>CMR<sub>o2</sub> was unaltered during 3-OHB infusion CTR (128.1&#x000b1;4.4 umol/100 ml/min) vs KET (126.0&#x000b1;3.6 umol/100 ml/min), p = 0.71 (t-test) (<xref ref-type="fig" rid="pone.0190556.g003">Fig 3C</xref>) whereas the oxygen extraction was lower in KET (0.26&#x000b1;0.01 umol/partiel O2 pressure/ml) as compared with CTR (0.31&#x000b1;0.02 umol/partiel O2 pressure/ml), p = 0.04 (t-test).</p></sec></sec><sec sec-type="conclusions" id="sec014"><title>Discussion</title><p>Our study was designed to test whether an acute 4-h infusion with a high dose of 3-OHB affects CBF together with oxygen and glucose utilisation in humans using modern PET and MRI techniques. The main findings of this study using these techniques are that CMR<sub>glu</sub> decreases 14% and CBF increases 30% under the influence of high 3-OHB concentrations. The 3-OHB concentrations in this study are equal to those seen after 4&#x02013;8 weeks of fasting [<xref rid="pone.0190556.ref018" ref-type="bibr">18</xref>].</p><p>Our findings are in line with previous findings of substantially globally increased CBF, decreased CMR<sub>glu</sub> and unaltered oxygen utilisation in rats [<xref rid="pone.0190556.ref020" ref-type="bibr">20</xref>] and in humans[<xref rid="pone.0190556.ref021" ref-type="bibr">21</xref>] measured with the Kety&#x02014;Schmidt technique and internal jugular vein catheterisations. The human study also used PET-FDG to assess regional glucose metabolism, but did not report absolute changes in PET-determined glucose metabolism and only found minor regional differences of normalised rCMTglucose values. It should be noted that the study performed in humans used a lower infusion rate, resulting in concentrations of around 2 mmol/l of 3-OHB corresponding to 5&#x02013;6 days of fasting[<xref rid="pone.0190556.ref033" ref-type="bibr">33</xref>]. Futhermore, the infusion was carried out for &#x0201c;3&#x02013;3.5&#x0201d; h, &#x0201c;4&#x02013;5 h&#x0201d; after a morning meal, implying that steady state conditions may not have been accomplished.</p><p>The 14% decrease in CMR<sub>glu</sub> is somewhat lower than the 33% decrease found by <italic>Hasselbalch et al</italic>. It should be noted that circulating glucose levels were slightly, but significantly, elevated preceding the 3-OHB infusion. Insulin levels however were not significantly different, so this in all likelihood is an accidental finding; if anything increased glucose concentrations would tend to increase cerebral glucose uptake and metabolism as opposed to the 14% decrease observed after 3-OHB administration. The slight decrease in plasma glucose following infusion of 3-OHB that we observed, is not expected to play any significant role [<xref rid="pone.0190556.ref034" ref-type="bibr">34</xref>]. Age is thought to be important for the 3-OHB impact on CMR<sub>glu</sub> as cerebral glucose consumption and metabolic flexibility decrease some 20% with age in humans[<xref rid="pone.0190556.ref023" ref-type="bibr">23</xref>] and some 30% in rats [<xref rid="pone.0190556.ref024" ref-type="bibr">24</xref>]. It has previously been found in rats, that one could expect a 9% decrease in CMR<sub>glu</sub> pr 1 mmol/l increase in 3-OHB but again this finding was made in the young rats, and may not be relevant for older human beings[<xref rid="pone.0190556.ref019" ref-type="bibr">19</xref>]. The 14% reduction in CMR<sub>glu</sub> may to large extent be explained by substrate competition between glucose and 3-OHB as originally described by <italic>Randle et al</italic>[<xref rid="pone.0190556.ref035" ref-type="bibr">35</xref>] in their seminal conceptual proposal which assigned important roles to both FFA and ketone bodies. It is unlikely that the recorded 0.1 mmol/l increase in lactate plays any significant role in this context[<xref rid="pone.0190556.ref036" ref-type="bibr">36</xref>].</p><p>CBF is tightly auto-regulated by oxygen supply and carbondioxide accumulation to secure constant conditions for the brain. As mentioned above <italic>Hasselbalch et al</italic> [<xref rid="pone.0190556.ref021" ref-type="bibr">21</xref>] reported a 40% increase in CBF in young human volunteers during short-term infusion of 3-OHB, a finding that could not be explained by alterations in CO<sub>2</sub> tension or pH. This study was expanded in a rat model[<xref rid="pone.0190556.ref020" ref-type="bibr">20</xref>], but again without identification of a specific mechanism, despite thorough investigations of classic vascular and intracerebral regulators of CBF (pH, PaO2 and PaCO2). It remains possible that the ability of 3-OHB to restrict oxidative stress may induce vasodilation and increase blood flow[<xref rid="pone.0190556.ref010" ref-type="bibr">10</xref>, <xref rid="pone.0190556.ref012" ref-type="bibr">12</xref>, <xref rid="pone.0190556.ref037" ref-type="bibr">37</xref>]. Another plausible mechanism proposed by <italic>Vlassenko et al</italic> [<xref rid="pone.0190556.ref038" ref-type="bibr">38</xref>] links increased CBF with an increase in NADH/NAD+ as the result from 3-OHB conversion to acetoacetate.</p><p>The CMR<sub>o2</sub> remained unchanged regardless of the two experimental conditions. As the CBF increased and the associated oxygen delivery was more or less unchanged, the oxygen extraction consequently decreased during hyperketonemia. This finding is supported by <italic>Hasselbalck et al</italic>, who did not find any altertions in oxygen consumption in the brain during hyperketonaemia. Studies in perfused rat hearts have indicated that addition of ketone bodies to the perfusate may increase hydraulic work efficiency per oxygene unit by 25%[<xref rid="pone.0190556.ref039" ref-type="bibr">39</xref>]. It has also been shown, that 3-OHB increases survival time to hypoxia markedly, up to four times[<xref rid="pone.0190556.ref040" ref-type="bibr">40</xref>]. A more recent study reported that 3-hydroxybutyrate infusion in ischemia induced by transient middle cerebral artery occlusion in mice, reduced infarct size, mediated by sirtuin 3, increased complex I activity in the mitochondria, and reduced ROS production [<xref rid="pone.0190556.ref041" ref-type="bibr">41</xref>]. In the mitochondria 3-OHB is also known to increase respiration resulting in increased brain derived neurotrophic factor expression, which in turn could also contribute to the neuro-beneficial effects of 3-OHB[<xref rid="pone.0190556.ref042" ref-type="bibr">42</xref>].</p><p>In conclusion we find that infusion with 3-OHB acutely increases CBF, and decreases CMR<sub>glu</sub> in all measured regions of the brain. Increased oxygen supply and unchanged oxygen utilisation may&#x02014;perhaps together with a favourable oxygen-ATP ratio and diminished oxidative stress&#x02014;contribute to the neuroprotective effects of ketone bodies.</p></sec><sec sec-type="supplementary-material" id="sec015"><title>Supporting information</title><supplementary-material content-type="local-data" id="pone.0190556.s001"><label>S1 Fig</label><caption><p>(PDF)</p></caption><media xlink:href="pone.0190556.s001.pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0190556.s002"><label>S1 Table</label><caption><p>(PDF)</p></caption><media xlink:href="pone.0190556.s002.pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0190556.s003"><label>S1 Text</label><caption><p>(PDF)</p></caption><media xlink:href="pone.0190556.s003.pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0190556.s004"><label>S2 Text</label><caption><p>(PDF)</p></caption><media xlink:href="pone.0190556.s004.pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack><p>The authors would like to thank Annette Mengel and Karen Mathiassen from Department of Clinical Medicine, Aarhus University Hospital, Denmark, and Mie Ringgaard Dollerup, Maria Louise Flink Schwartz, Lone Korsgaard, Rikke Bertelsen, Khalida Akbari, and Dorte Schmidt Jespersen from Department of nuclear medicine and PET Center, Aarhus University Hospital, Denmark for their excellent technical assistance and consistent work throughout the study. Likewise, the authors would like to thank the nine participants for participation and completion of the study days.</p></ack><ref-list><title>References</title><ref id="pone.0190556.ref001"><label>1</label><mixed-citation publication-type="journal"><name><surname>Longo</surname><given-names>VD</given-names></name>, <name><surname>Panda</surname><given-names>S</given-names></name>. <article-title>Fasting, Circadian Rhythms, and Time-Restricted Feeding in Healthy Lifespan</article-title>. <source>Cell metabolism</source>. <year>2016</year>;<volume>23</volume>(<issue>6</issue>):<fpage>1048</fpage>&#x02013;<lpage>59</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.cmet.2016.06.001">10.1016/j.cmet.2016.06.001</ext-link></comment> .<pub-id pub-id-type="pmid">27304506</pub-id></mixed-citation></ref><ref id="pone.0190556.ref002"><label>2</label><mixed-citation publication-type="journal"><name><surname>Zinman</surname><given-names>B</given-names></name>, <name><surname>Wanner</surname><given-names>C</given-names></name>, <name><surname>Lachin</surname><given-names>JM</given-names></name>, <name><surname>Fitchett</surname><given-names>D</given-names></name>, <name><surname>Bluhmki</surname><given-names>E</given-names></name>, <name><surname>Hantel</surname><given-names>S</given-names></name>, <etal>et al</etal>
<article-title>Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes</article-title>. <source>The New England journal of medicine</source>. <year>2015</year>;<volume>373</volume>(<issue>22</issue>):<fpage>2117</fpage>&#x02013;<lpage>28</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1056/NEJMoa1504720">10.1056/NEJMoa1504720</ext-link></comment> .<pub-id pub-id-type="pmid">26378978</pub-id></mixed-citation></ref><ref id="pone.0190556.ref003"><label>3</label><mixed-citation publication-type="journal"><name><surname>Edwards</surname><given-names>C</given-names></name>, <name><surname>Canfield</surname><given-names>J</given-names></name>, <name><surname>Copes</surname><given-names>N</given-names></name>, <name><surname>Rehan</surname><given-names>M</given-names></name>, <name><surname>Lipps</surname><given-names>D</given-names></name>, <name><surname>Bradshaw</surname><given-names>PC</given-names></name>. <article-title>D-beta-hydroxybutyrate extends lifespan in C. elegans</article-title>. <source>Aging (Albany NY)</source>. <year>2014</year>;<volume>6</volume>(<issue>8</issue>):<fpage>621</fpage>&#x02013;<lpage>44</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.18632/aging.100683">10.18632/aging.100683</ext-link></comment> ; PubMed Central PMCID: PMCPMC4169858.<pub-id pub-id-type="pmid">25127866</pub-id></mixed-citation></ref><ref id="pone.0190556.ref004"><label>4</label><mixed-citation publication-type="journal"><name><surname>Owen</surname><given-names>OE</given-names></name>, <name><surname>Morgan</surname><given-names>AP</given-names></name>, <name><surname>Kemp</surname><given-names>HG</given-names></name>, <name><surname>Sullivan</surname><given-names>JM</given-names></name>, <name><surname>Herrera</surname><given-names>MG</given-names></name>, <name><surname>Cahill</surname><given-names>GF</given-names><suffix>Jr</suffix></name>. <article-title>Brain metabolism during fasting</article-title>. <source>J Clin Invest</source>. <year>1967</year>;<volume>46</volume>(<issue>10</issue>):<fpage>1589</fpage>&#x02013;<lpage>95</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1172/JCI105650">10.1172/JCI105650</ext-link></comment> ; PubMed Central PMCID: PMCPMC292907.<pub-id pub-id-type="pmid">6061736</pub-id></mixed-citation></ref><ref id="pone.0190556.ref005"><label>5</label><mixed-citation publication-type="journal"><name><surname>Cahill</surname><given-names>GF</given-names><suffix>Jr</suffix></name>. <article-title>Starvation in man</article-title>. <source>The New England journal of medicine</source>. <year>1970</year>;<volume>282</volume>(<issue>12</issue>):<fpage>668</fpage>&#x02013;<lpage>75</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1056/NEJM197003192821209">10.1056/NEJM197003192821209</ext-link></comment> .<pub-id pub-id-type="pmid">4915800</pub-id></mixed-citation></ref><ref id="pone.0190556.ref006"><label>6</label><mixed-citation publication-type="journal"><name><surname>Schonfeld</surname><given-names>P</given-names></name>, <name><surname>Reiser</surname><given-names>G</given-names></name>. <article-title>Why does brain metabolism not favor burning of fatty acids to provide energy? Reflections on disadvantages of the use of free fatty acids as fuel for brain. Journal of cerebral blood flow and metabolism: official journal of the</article-title>
<source>International Society of Cerebral Blood Flow and Metabolism</source>. <year>2013</year>;<volume>33</volume>(<issue>10</issue>):<fpage>1493</fpage>&#x02013;<lpage>9</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/jcbfm.2013.128">10.1038/jcbfm.2013.128</ext-link></comment> ; PubMed Central PMCID: PMCPMC3790936.<pub-id pub-id-type="pmid">23921897</pub-id></mixed-citation></ref><ref id="pone.0190556.ref007"><label>7</label><mixed-citation publication-type="journal"><name><surname>Bouteldja</surname><given-names>N</given-names></name>, <name><surname>Andersen</surname><given-names>LT</given-names></name>, <name><surname>Moller</surname><given-names>N</given-names></name>, <name><surname>Gormsen</surname><given-names>LC</given-names></name>. <article-title>Using positron emission tomography to study human ketone body metabolism: a review</article-title>. <source>Metabolism: clinical and experimental</source>. <year>2014</year>;<volume>63</volume>(<issue>11</issue>):<fpage>1375</fpage>&#x02013;<lpage>84</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.metabol.2014.08.001">10.1016/j.metabol.2014.08.001</ext-link></comment> .<pub-id pub-id-type="pmid">25195069</pub-id></mixed-citation></ref><ref id="pone.0190556.ref008"><label>8</label><mixed-citation publication-type="journal"><name><surname>Veech</surname><given-names>RL</given-names></name>, <name><surname>Chance</surname><given-names>B</given-names></name>, <name><surname>Kashiwaya</surname><given-names>Y</given-names></name>, <name><surname>Lardy</surname><given-names>HA</given-names></name>, <name><surname>Cahill</surname><given-names>GF</given-names><suffix>Jr</suffix></name>. <article-title>Ketone bodies, potential therapeutic uses</article-title>. <source>IUBMB life</source>. <year>2001</year>;<volume>51</volume>(<issue>4</issue>):<fpage>241</fpage>&#x02013;<lpage>7</lpage>. Epub 2001/09/25. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1080/152165401753311780">10.1080/152165401753311780</ext-link></comment> .<pub-id pub-id-type="pmid">11569918</pub-id></mixed-citation></ref><ref id="pone.0190556.ref009"><label>9</label><mixed-citation publication-type="journal"><name><surname>Mudaliar</surname><given-names>S</given-names></name>, <name><surname>Alloju</surname><given-names>S</given-names></name>, <name><surname>Henry</surname><given-names>RR</given-names></name>. <article-title>Can a Shift in Fuel Energetics Explain the Beneficial Cardiorenal Outcomes in the EMPA-REG OUTCOME Study?</article-title>
<source>A Unifying Hypothesis. Diabetes Care</source>. <year>2016</year>;<volume>39</volume>(<issue>7</issue>):<fpage>1115</fpage>&#x02013;<lpage>22</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.2337/dc16-0542">10.2337/dc16-0542</ext-link></comment> .<pub-id pub-id-type="pmid">27289124</pub-id></mixed-citation></ref><ref id="pone.0190556.ref010"><label>10</label><mixed-citation publication-type="journal"><name><surname>Chang</surname><given-names>AS</given-names></name>, <name><surname>D'Alecy</surname><given-names>LG</given-names></name>. <article-title>Hypoxia and beta-hydroxybutyrate acutely reduce glucose extraction by the brain in anesthetized dogs</article-title>. <source>Can J Physiol Pharmacol</source>. <year>1993</year>;<volume>71</volume>(<issue>7</issue>):<fpage>465</fpage>&#x02013;<lpage>72</lpage>. .<pub-id pub-id-type="pmid">8242480</pub-id></mixed-citation></ref><ref id="pone.0190556.ref011"><label>11</label><mixed-citation publication-type="journal"><name><surname>Maalouf</surname><given-names>M</given-names></name>, <name><surname>Sullivan</surname><given-names>PG</given-names></name>, <name><surname>Davis</surname><given-names>L</given-names></name>, <name><surname>Kim</surname><given-names>DY</given-names></name>, <name><surname>Rho</surname><given-names>JM</given-names></name>. <article-title>Ketones inhibit mitochondrial production of reactive oxygen species production following glutamate excitotoxicity by increasing NADH oxidation</article-title>. <source>Neuroscience</source>. <year>2007</year>;<volume>145</volume>(<issue>1</issue>):<fpage>256</fpage>&#x02013;<lpage>64</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.neuroscience.2006.11.065">10.1016/j.neuroscience.2006.11.065</ext-link></comment> ; PubMed Central PMCID: PMCPMC1865572.<pub-id pub-id-type="pmid">17240074</pub-id></mixed-citation></ref><ref id="pone.0190556.ref012"><label>12</label><mixed-citation publication-type="journal"><name><surname>Shimazu</surname><given-names>T</given-names></name>, <name><surname>Hirschey</surname><given-names>MD</given-names></name>, <name><surname>Newman</surname><given-names>J</given-names></name>, <name><surname>He</surname><given-names>W</given-names></name>, <name><surname>Shirakawa</surname><given-names>K</given-names></name>, <name><surname>Le Moan</surname><given-names>N</given-names></name>, <etal>et al</etal>
<article-title>Suppression of oxidative stress by beta-hydroxybutyrate, an endogenous histone deacetylase inhibitor</article-title>. <source>Science</source>. <year>2013</year>;<volume>339</volume>(<issue>6116</issue>):<fpage>211</fpage>&#x02013;<lpage>4</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1126/science.1227166">10.1126/science.1227166</ext-link></comment> ; PubMed Central PMCID: PMCPMC3735349.<pub-id pub-id-type="pmid">23223453</pub-id></mixed-citation></ref><ref id="pone.0190556.ref013"><label>13</label><mixed-citation publication-type="journal"><name><surname>Sleiman</surname><given-names>SF</given-names></name>, <name><surname>Henry</surname><given-names>J</given-names></name>, <name><surname>Al-Haddad</surname><given-names>R</given-names></name>, <name><surname>El Hayek</surname><given-names>L</given-names></name>, <name><surname>Abou Haidar</surname><given-names>E</given-names></name>, <name><surname>Stringer</surname><given-names>T</given-names></name>, <etal>et al</etal>
<article-title>Exercise promotes the expression of brain derived neurotrophic factor (BDNF) through the action of the ketone body beta-hydroxybutyrate</article-title>. <source>Elife</source>. <year>2016</year>;<volume>5</volume>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.7554/eLife.15092">10.7554/eLife.15092</ext-link></comment> ; PubMed Central PMCID: PMCPMC4915811.<pub-id pub-id-type="pmid">27253067</pub-id></mixed-citation></ref><ref id="pone.0190556.ref014"><label>14</label><mixed-citation publication-type="journal"><name><surname>Korsholm</surname><given-names>K</given-names></name>, <name><surname>Law</surname><given-names>I</given-names></name>. <article-title>Effects of a ketogenic diet on brain metabolism in epilepsy</article-title>. <source>Clin Nucl Med</source>. <year>2013</year>;<volume>38</volume>(<issue>1</issue>):<fpage>38</fpage>&#x02013;<lpage>9</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1097/RLU.0b013e31827082c4">10.1097/RLU.0b013e31827082c4</ext-link></comment> .<pub-id pub-id-type="pmid">23242044</pub-id></mixed-citation></ref><ref id="pone.0190556.ref015"><label>15</label><mixed-citation publication-type="journal"><name><surname>Neal</surname><given-names>EG</given-names></name>, <name><surname>Chaffe</surname><given-names>H</given-names></name>, <name><surname>Schwartz</surname><given-names>RH</given-names></name>, <name><surname>Lawson</surname><given-names>MS</given-names></name>, <name><surname>Edwards</surname><given-names>N</given-names></name>, <name><surname>Fitzsimmons</surname><given-names>G</given-names></name>, <etal>et al</etal>
<article-title>The ketogenic diet for the treatment of childhood epilepsy: a randomised controlled trial</article-title>. <source>Lancet Neurol</source>. <year>2008</year>;<volume>7</volume>(<issue>6</issue>):<fpage>500</fpage>&#x02013;<lpage>6</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/S1474-4422(08)70092-9">10.1016/S1474-4422(08)70092-9</ext-link></comment> .<pub-id pub-id-type="pmid">18456557</pub-id></mixed-citation></ref><ref id="pone.0190556.ref016"><label>16</label><mixed-citation publication-type="journal"><name><surname>Kashiwaya</surname><given-names>Y</given-names></name>, <name><surname>Takeshima</surname><given-names>T</given-names></name>, <name><surname>Mori</surname><given-names>N</given-names></name>, <name><surname>Nakashima</surname><given-names>K</given-names></name>, <name><surname>Clarke</surname><given-names>K</given-names></name>, <name><surname>Veech</surname><given-names>RL</given-names></name>. <article-title>D-beta-hydroxybutyrate protects neurons in models of Alzheimer's and Parkinson's disease</article-title>. <source>Proceedings of the National Academy of Sciences of the United States of America</source>. <year>2000</year>;<volume>97</volume>(<issue>10</issue>):<fpage>5440</fpage>&#x02013;<lpage>4</lpage>. ; PubMed Central PMCID: PMC25847.<pub-id pub-id-type="pmid">10805800</pub-id></mixed-citation></ref><ref id="pone.0190556.ref017"><label>17</label><mixed-citation publication-type="journal"><name><surname>Cunnane</surname><given-names>S</given-names></name>, <name><surname>Nugent</surname><given-names>S</given-names></name>, <name><surname>Roy</surname><given-names>M</given-names></name>, <name><surname>Courchesne-Loyer</surname><given-names>A</given-names></name>, <name><surname>Croteau</surname><given-names>E</given-names></name>, <name><surname>Tremblay</surname><given-names>S</given-names></name>, <etal>et al</etal>
<article-title>Brain fuel metabolism, aging, and Alzheimer's disease</article-title>. <source>Nutrition</source>. <year>2011</year>;<volume>27</volume>(<issue>1</issue>):<fpage>3</fpage>&#x02013;<lpage>20</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.nut.2010.07.021">10.1016/j.nut.2010.07.021</ext-link></comment> ; PubMed Central PMCID: PMCPMC3478067.<pub-id pub-id-type="pmid">21035308</pub-id></mixed-citation></ref><ref id="pone.0190556.ref018"><label>18</label><mixed-citation publication-type="journal"><name><surname>Redies</surname><given-names>C</given-names></name>, <name><surname>Hoffer</surname><given-names>LJ</given-names></name>, <name><surname>Beil</surname><given-names>C</given-names></name>, <name><surname>Marliss</surname><given-names>EB</given-names></name>, <name><surname>Evans</surname><given-names>AC</given-names></name>, <name><surname>Lariviere</surname><given-names>F</given-names></name>, <etal>et al</etal>
<article-title>Generalized decrease in brain glucose metabolism during fasting in humans studied by PET</article-title>. <source>The American journal of physiology</source>. <year>1989</year>;<volume>256</volume>(<issue>6</issue> Pt 1):<fpage>E805</fpage>&#x02013;<lpage>10</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1152/ajpendo.1989.256.6.E805">10.1152/ajpendo.1989.256.6.E805</ext-link></comment> .<pub-id pub-id-type="pmid">2786677</pub-id></mixed-citation></ref><ref id="pone.0190556.ref019"><label>19</label><mixed-citation publication-type="journal"><name><surname>Zhang</surname><given-names>Y</given-names></name>, <name><surname>Kuang</surname><given-names>Y</given-names></name>, <name><surname>Xu</surname><given-names>K</given-names></name>, <name><surname>Harris</surname><given-names>D</given-names></name>, <name><surname>Lee</surname><given-names>Z</given-names></name>, <name><surname>LaManna</surname><given-names>J</given-names></name>, <etal>et al</etal>
<article-title>Ketosis proportionately spares glucose utilization in brain</article-title>. <source>Journal of cerebral blood flow and metabolism: official journal of the International Society of Cerebral Blood Flow and Metabolism</source>. <year>2013</year>;<volume>33</volume>(<issue>8</issue>):<fpage>1307</fpage>&#x02013;<lpage>11</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/jcbfm.2013.87">10.1038/jcbfm.2013.87</ext-link></comment> ; PubMed Central PMCID: PMC3734783.<pub-id pub-id-type="pmid">23736643</pub-id></mixed-citation></ref><ref id="pone.0190556.ref020"><label>20</label><mixed-citation publication-type="journal"><name><surname>Linde</surname><given-names>R</given-names></name>, <name><surname>Hasselbalch</surname><given-names>SG</given-names></name>, <name><surname>Topp</surname><given-names>S</given-names></name>, <name><surname>Paulson</surname><given-names>OB</given-names></name>, <name><surname>Madsen</surname><given-names>PL</given-names></name>. <article-title>Global cerebral blood flow and metabolism during acute hyperketonemia in the awake and anesthetized rat</article-title>. <source>Journal of cerebral blood flow and metabolism: official journal of the International Society of Cerebral Blood Flow and Metabolism</source>. <year>2006</year>;<volume>26</volume>(<issue>2</issue>):<fpage>170</fpage>&#x02013;<lpage>80</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/sj.jcbfm.9600177">10.1038/sj.jcbfm.9600177</ext-link></comment> .<pub-id pub-id-type="pmid">16001018</pub-id></mixed-citation></ref><ref id="pone.0190556.ref021"><label>21</label><mixed-citation publication-type="journal"><name><surname>Hasselbalch</surname><given-names>SG</given-names></name>, <name><surname>Madsen</surname><given-names>PL</given-names></name>, <name><surname>Hageman</surname><given-names>LP</given-names></name>, <name><surname>Olsen</surname><given-names>KS</given-names></name>, <name><surname>Justesen</surname><given-names>N</given-names></name>, <name><surname>Holm</surname><given-names>S</given-names></name>, <etal>et al</etal>
<article-title>Changes in cerebral blood flow and carbohydrate metabolism during acute hyperketonemia</article-title>. <source>The American journal of physiology</source>. <year>1996</year>;<volume>270</volume>(<issue>5</issue> Pt 1):<fpage>E746</fpage>&#x02013;<lpage>51</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1152/ajpendo.1996.270.5.E746">10.1152/ajpendo.1996.270.5.E746</ext-link></comment> .<pub-id pub-id-type="pmid">8967461</pub-id></mixed-citation></ref><ref id="pone.0190556.ref022"><label>22</label><mixed-citation publication-type="journal"><name><surname>Mikkelsen</surname><given-names>KH</given-names></name>, <name><surname>Seifert</surname><given-names>T</given-names></name>, <name><surname>Secher</surname><given-names>NH</given-names></name>, <name><surname>Grondal</surname><given-names>T</given-names></name>, <name><surname>van Hall</surname><given-names>G</given-names></name>. <article-title>Systemic, cerebral and skeletal muscle ketone body and energy metabolism during acute hyper-D-beta-hydroxybutyratemia in post-absorptive healthy males</article-title>. <source>The Journal of clinical endocrinology and metabolism</source>. <year>2015</year>;<volume>100</volume>(<issue>2</issue>):<fpage>636</fpage>&#x02013;<lpage>43</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1210/jc.2014-2608">10.1210/jc.2014-2608</ext-link></comment> .<pub-id pub-id-type="pmid">25415176</pub-id></mixed-citation></ref><ref id="pone.0190556.ref023"><label>23</label><mixed-citation publication-type="journal"><name><surname>Shen</surname><given-names>XY</given-names></name>, <name><surname>Liu</surname><given-names>HF</given-names></name>, <name><surname>Hu</surname><given-names>ZH</given-names></name>, <name><surname>Hu</surname><given-names>HJ</given-names></name>, <name><surname>Shi</surname><given-names>PC</given-names></name>. <article-title>The Relationship between Cerebral Glucose Metabolism and Age: Report of a Large Brain PET Data Set</article-title>. <source>PloS one</source>. <year>2012</year>;<volume>7</volume>(<issue>12</issue>). doi: ARTN e51517 <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pone.0051517">10.1371/journal.pone.0051517</ext-link></comment> PubMed PMID: WOS:000312794500031. <pub-id pub-id-type="pmid">23284706</pub-id></mixed-citation></ref><ref id="pone.0190556.ref024"><label>24</label><mixed-citation publication-type="journal"><name><surname>Hoyer</surname><given-names>S</given-names></name>. <article-title>The Effect of Age on Glucose and Energy-Metabolism in Brain Cortex of Rats</article-title>. <source>Arch Gerontol Geriat</source>. <year>1985</year>;<volume>4</volume>(<issue>3</issue>):<fpage>193</fpage>&#x02013;<lpage>203</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/0167-4943(85)90001-9">10.1016/0167-4943(85)90001-9</ext-link></comment> PubMed PMID: WOS:A1985AUM4400001.</mixed-citation></ref><ref id="pone.0190556.ref025"><label>25</label><mixed-citation publication-type="journal"><name><surname>Mosconi</surname><given-names>L</given-names></name>. <article-title>Glucose metabolism in normal aging and Alzheimer's disease: Methodological and physiological considerations for PET studies</article-title>. <source>Clin Transl Imaging</source>. <year>2013</year>;<volume>1</volume>(<issue>4</issue>). <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s40336-013-0026-y">10.1007/s40336-013-0026-y</ext-link></comment> ; PubMed Central PMCID: PMCPMC3881550.<pub-id pub-id-type="pmid">24409422</pub-id></mixed-citation></ref><ref id="pone.0190556.ref026"><label>26</label><mixed-citation publication-type="journal"><name><surname>Sorensen</surname><given-names>LK</given-names></name>, <name><surname>Rittig</surname><given-names>NF</given-names></name>, <name><surname>Holmquist</surname><given-names>EF</given-names></name>, <name><surname>Jorgensen</surname><given-names>KA</given-names></name>, <name><surname>Jorgensen</surname><given-names>JO</given-names></name>, <name><surname>Moller</surname><given-names>N</given-names></name>, <etal>et al</etal>
<article-title>Simultaneous determination of beta-hydroxybutyrate and beta-hydroxy-beta-methylbutyrate in human whole blood using hydrophilic interaction liquid chromatography electrospray tandem mass spectrometry</article-title>. <source>Clin Biochem</source>. <year>2013</year>;<volume>46</volume>(<issue>18</issue>):<fpage>1877</fpage>&#x02013;<lpage>83</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.clinbiochem.2013.08.011">10.1016/j.clinbiochem.2013.08.011</ext-link></comment> .<pub-id pub-id-type="pmid">23994603</pub-id></mixed-citation></ref><ref id="pone.0190556.ref027"><label>27</label><mixed-citation publication-type="journal"><name><surname>Grabner</surname><given-names>G</given-names></name>, <name><surname>Janke</surname><given-names>AL</given-names></name>, <name><surname>Budge</surname><given-names>MM</given-names></name>, <name><surname>Smith</surname><given-names>D</given-names></name>, <name><surname>Pruessner</surname><given-names>J</given-names></name>, <name><surname>Collins</surname><given-names>DL</given-names></name>. <article-title>Symmetric atlasing and model based segmentation: an application to the hippocampus in older adults</article-title>. <source>Med Image Comput Comput Assist Interv</source>. <year>2006</year>;<volume>9</volume>(<issue>Pt 2</issue>):<fpage>58</fpage>&#x02013;<lpage>66</lpage>. .<pub-id pub-id-type="pmid">17354756</pub-id></mixed-citation></ref><ref id="pone.0190556.ref028"><label>28</label><mixed-citation publication-type="journal"><name><surname>Blomqvist</surname><given-names>G</given-names></name>. <article-title>On the construction of functional maps in positron emission tomography</article-title>. <source>Journal of cerebral blood flow and metabolism: official journal of the International Society of Cerebral Blood Flow and Metabolism</source>. <year>1984</year>;<volume>4</volume>(<issue>4</issue>):<fpage>629</fpage>&#x02013;<lpage>32</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/jcbfm.1984.89">10.1038/jcbfm.1984.89</ext-link></comment> .<pub-id pub-id-type="pmid">6334095</pub-id></mixed-citation></ref><ref id="pone.0190556.ref029"><label>29</label><mixed-citation publication-type="journal"><name><surname>Ohta</surname><given-names>S</given-names></name>, <name><surname>Meyer</surname><given-names>E</given-names></name>, <name><surname>Fujita</surname><given-names>H</given-names></name>, <name><surname>Reutens</surname><given-names>DC</given-names></name>, <name><surname>Evans</surname><given-names>A</given-names></name>, <name><surname>Gjedde</surname><given-names>A</given-names></name>. <article-title>Cerebral [15O]water clearance in humans determined by PET: I. Theory and normal values</article-title>. <source>Journal of cerebral blood flow and metabolism: official journal of the International Society of Cerebral Blood Flow and Metabolism</source>. <year>1996</year>;<volume>16</volume>(<issue>5</issue>):<fpage>765</fpage>&#x02013;<lpage>80</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1097/00004647-199609000-00002">10.1097/00004647-199609000-00002</ext-link></comment> .<pub-id pub-id-type="pmid">8784222</pub-id></mixed-citation></ref><ref id="pone.0190556.ref030"><label>30</label><mixed-citation publication-type="journal"><name><surname>Ohta</surname><given-names>S</given-names></name>, <name><surname>Meyer</surname><given-names>E</given-names></name>, <name><surname>Thompson</surname><given-names>CJ</given-names></name>, <name><surname>Gjedde</surname><given-names>A</given-names></name>. <article-title>Oxygen consumption of the living human brain measured after a single inhalation of positron emitting oxygen</article-title>. <source>Journal of cerebral blood flow and metabolism: official journal of the International Society of Cerebral Blood Flow and Metabolism</source>. <year>1992</year>;<volume>12</volume>(<issue>2</issue>):<fpage>179</fpage>&#x02013;<lpage>92</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/jcbfm.1992.28">10.1038/jcbfm.1992.28</ext-link></comment> .<pub-id pub-id-type="pmid">1548291</pub-id></mixed-citation></ref><ref id="pone.0190556.ref031"><label>31</label><mixed-citation publication-type="journal"><name><surname>Patlak</surname><given-names>CS</given-names></name>, <name><surname>Blasberg</surname><given-names>RG</given-names></name>, <name><surname>Fenstermacher</surname><given-names>JD</given-names></name>. <article-title>Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data</article-title>. <source>Journal of cerebral blood flow and metabolism: official journal of the International Society of Cerebral Blood Flow and Metabolism</source>. <year>1983</year>;<volume>3</volume>(<issue>1</issue>):<fpage>1</fpage>&#x02013;<lpage>7</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/jcbfm.1983.1">10.1038/jcbfm.1983.1</ext-link></comment> .<pub-id pub-id-type="pmid">6822610</pub-id></mixed-citation></ref><ref id="pone.0190556.ref032"><label>32</label><mixed-citation publication-type="journal"><name><surname>Graham</surname><given-names>MM</given-names></name>, <name><surname>Muzi</surname><given-names>M</given-names></name>, <name><surname>Spence</surname><given-names>AM</given-names></name>, <name><surname>O'Sullivan</surname><given-names>F</given-names></name>, <name><surname>Lewellen</surname><given-names>TK</given-names></name>, <name><surname>Link</surname><given-names>JM</given-names></name>, <etal>et al</etal>
<article-title>The FDG lumped constant in normal human brain</article-title>. <source>J Nucl Med</source>. <year>2002</year>;<volume>43</volume>(<issue>9</issue>):<fpage>1157</fpage>&#x02013;<lpage>66</lpage>. .<pub-id pub-id-type="pmid">12215553</pub-id></mixed-citation></ref><ref id="pone.0190556.ref033"><label>33</label><mixed-citation publication-type="journal"><name><surname>Robinson</surname><given-names>AM</given-names></name>, <name><surname>Williamson</surname><given-names>DH</given-names></name>. <article-title>Physiological roles of ketone bodies as substrates and signals in mammalian tissues</article-title>. <source>Physiol Rev</source>. <year>1980</year>;<volume>60</volume>(<issue>1</issue>):<fpage>143</fpage>&#x02013;<lpage>87</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1152/physrev.1980.60.1.143">10.1152/physrev.1980.60.1.143</ext-link></comment> .<pub-id pub-id-type="pmid">6986618</pub-id></mixed-citation></ref><ref id="pone.0190556.ref034"><label>34</label><mixed-citation publication-type="journal"><name><surname>Redies</surname><given-names>C</given-names></name>, <name><surname>Hoffer</surname><given-names>LJ</given-names></name>, <name><surname>Beil</surname><given-names>C</given-names></name>, <name><surname>Marliss</surname><given-names>EB</given-names></name>, <name><surname>Evans</surname><given-names>AC</given-names></name>, <name><surname>Lariviere</surname><given-names>F</given-names></name>, <etal>et al</etal>
<article-title>Generalized Decrease in Brain Glucose-Metabolism during Fasting in Humans Studied by Pet</article-title>. <source>American Journal of Physiology</source>. <year>1989</year>;<volume>256</volume>(<issue>6</issue>):<fpage>E805</fpage>&#x02013;<lpage>E10</lpage>. PubMed PMID: WOS:A1989AC79200038.<pub-id pub-id-type="pmid">2786677</pub-id></mixed-citation></ref><ref id="pone.0190556.ref035"><label>35</label><mixed-citation publication-type="journal"><name><surname>Randle</surname><given-names>PJ</given-names></name>, <name><surname>Garland</surname><given-names>PB</given-names></name>, <name><surname>Hales</surname><given-names>CN</given-names></name>, <name><surname>Newsholme</surname><given-names>EA</given-names></name>. <article-title>The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus</article-title>. <source>Lancet</source>. <year>1963</year>;<volume>1</volume>(<issue>7285</issue>):<fpage>785</fpage>&#x02013;<lpage>9</lpage>. .<pub-id pub-id-type="pmid">13990765</pub-id></mixed-citation></ref><ref id="pone.0190556.ref036"><label>36</label><mixed-citation publication-type="journal"><name><surname>Dienel</surname><given-names>GA</given-names></name>. <article-title>Brain lactate metabolism: the discoveries and the controversies</article-title>. <source>Journal of cerebral blood flow and metabolism: official journal of the International Society of Cerebral Blood Flow and Metabolism</source>. <year>2012</year>;<volume>32</volume>(<issue>7</issue>):<fpage>1107</fpage>&#x02013;<lpage>38</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/jcbfm.2011.175">10.1038/jcbfm.2011.175</ext-link></comment> ; PubMed Central PMCID: PMCPMC3390802.<pub-id pub-id-type="pmid">22186669</pub-id></mixed-citation></ref><ref id="pone.0190556.ref037"><label>37</label><mixed-citation publication-type="journal"><name><surname>Forstermann</surname><given-names>U</given-names></name>, <name><surname>Xia</surname><given-names>N</given-names></name>, <name><surname>Li</surname><given-names>H</given-names></name>. <article-title>Roles of Vascular Oxidative Stress and Nitric Oxide in the Pathogenesis of Atherosclerosis</article-title>. <source>Circ Res</source>. <year>2017</year>;<volume>120</volume>(<issue>4</issue>):<fpage>713</fpage>&#x02013;<lpage>35</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1161/CIRCRESAHA.116.309326">10.1161/CIRCRESAHA.116.309326</ext-link></comment> .<pub-id pub-id-type="pmid">28209797</pub-id></mixed-citation></ref><ref id="pone.0190556.ref038"><label>38</label><mixed-citation publication-type="journal"><name><surname>Vlassenko</surname><given-names>AG</given-names></name>, <name><surname>Rundle</surname><given-names>MM</given-names></name>, <name><surname>Raichle</surname><given-names>ME</given-names></name>, <name><surname>Mintun</surname><given-names>MA</given-names></name>. <article-title>Regulation of blood flow in activated human brain by cytosolic NADH/NAD(+) ratio</article-title>. <source>Proceedings of the National Academy of Sciences of the United States of America</source>. <year>2006</year>;<volume>103</volume>(<issue>6</issue>):<fpage>1964</fpage>&#x02013;<lpage>9</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1073/pnas.0510632103">10.1073/pnas.0510632103</ext-link></comment> PubMed PMID: WOS:000235311300054. <pub-id pub-id-type="pmid">16446430</pub-id></mixed-citation></ref><ref id="pone.0190556.ref039"><label>39</label><mixed-citation publication-type="journal"><name><surname>Sato</surname><given-names>K</given-names></name>, <name><surname>Kashiwaya</surname><given-names>Y</given-names></name>, <name><surname>Keon</surname><given-names>CA</given-names></name>, <name><surname>Tsuchiya</surname><given-names>N</given-names></name>, <name><surname>King</surname><given-names>MT</given-names></name>, <name><surname>Radda</surname><given-names>GK</given-names></name>, <etal>et al</etal>
<article-title>Insulin, ketone bodies, and mitochondrial energy transduction</article-title>. <source>FASEB J</source>. <year>1995</year>;<volume>9</volume>(<issue>8</issue>):<fpage>651</fpage>&#x02013;<lpage>8</lpage>. .<pub-id pub-id-type="pmid">7768357</pub-id></mixed-citation></ref><ref id="pone.0190556.ref040"><label>40</label><mixed-citation publication-type="journal"><name><surname>Kirsch</surname><given-names>JR</given-names></name>, <name><surname>D'Alecy</surname><given-names>LG</given-names></name>, <name><surname>Mongroo</surname><given-names>PB</given-names></name>. <article-title>Butanediol induced ketosis increases tolerance to hypoxia in the mouse</article-title>. <source>Stroke; a journal of cerebral circulation</source>. <year>1980</year>;<volume>11</volume>(<issue>5</issue>):<fpage>506</fpage>&#x02013;<lpage>13</lpage>. .<pub-id pub-id-type="pmid">6775394</pub-id></mixed-citation></ref><ref id="pone.0190556.ref041"><label>41</label><mixed-citation publication-type="journal"><name><surname>Yin</surname><given-names>J</given-names></name>, <name><surname>Han</surname><given-names>P</given-names></name>, <name><surname>Tang</surname><given-names>Z</given-names></name>, <name><surname>Liu</surname><given-names>Q</given-names></name>, <name><surname>Shi</surname><given-names>J</given-names></name>. <article-title>Sirtuin 3 mediates neuroprotection of ketones against ischemic stroke</article-title>. <source>Journal of cerebral blood flow and metabolism: official journal of the International Society of Cerebral Blood Flow and Metabolism</source>. <year>2015</year>;<volume>35</volume>(<issue>11</issue>):<fpage>1783</fpage>&#x02013;<lpage>9</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/jcbfm.2015.123">10.1038/jcbfm.2015.123</ext-link></comment> ; PubMed Central PMCID: PMCPMC4635233.<pub-id pub-id-type="pmid">26058697</pub-id></mixed-citation></ref><ref id="pone.0190556.ref042"><label>42</label><mixed-citation publication-type="journal"><name><surname>Marosi</surname><given-names>K</given-names></name>, <name><surname>Kim</surname><given-names>SW</given-names></name>, <name><surname>Moehl</surname><given-names>K</given-names></name>, <name><surname>Scheibye-Knudsen</surname><given-names>M</given-names></name>, <name><surname>Cheng</surname><given-names>AW</given-names></name>, <name><surname>Cutler</surname><given-names>R</given-names></name>, <etal>et al</etal>
<article-title>3-Hydroxybutyrate regulates energy metabolism and induces BDNF expression in cerebral cortical neurons</article-title>. <source>Journal of Neurochemistry</source>. <year>2016</year>;<volume>139</volume>(<issue>5</issue>):<fpage>769</fpage>&#x02013;<lpage>81</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/jnc.13868">10.1111/jnc.13868</ext-link></comment> PubMed PMID: WOS:000389134800009. <pub-id pub-id-type="pmid">27739595</pub-id></mixed-citation></ref></ref-list></back></article>